ArticleFrontiers in bioengineering and biotechnology2025
Utilizing Detectron2 for accurate and efficient colon cancer detection in histopathological images.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Colon cancer ranks among the most prevalent and lethal cancers globally, emphasizing the urgent need for accurate and early diagnostic tools. Recent advances in deep learning have shown promise in medical image analysis, offering potential improvements in detection accuracy and efficiency. Methods: This study proposes a novel approach for classifying colon tissue images as normal or cancerous using Detectron2, a deep learning framework known for its superior object detection and segmentation capabilities. The model was adapted and optimized for histopathological image classification tasks. Training and evaluation were conducted on the LC25000 dataset, which contains 10,000 labeled images (5,000 normal and 5,000 cancerous). Results: The optimized Detectron2 model achieved an exceptional accuracy of 99.8%, significantly outperforming traditional image analysis methods. The framework demonstrated high computational efficiency and robustness in handling the complexity of medical image data. Discussion: These results highlight Detectron2's effectiveness as a powerful tool for computer-aided diagnostics in colon cancer detection. The approach shows strong potential for integration into clinical workflows, aiding pathologists in early diagnosis and contributing to improved patient outcomes. This study also illustrates the transformative impact of advanced machine learning techniques on medical imaging and cancer diagnostics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.